VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 138 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $284,000 | -62.6% | 60,228 | -43.2% | 0.00% | -66.7% |
| Q4 2020 | $759,000 | -42.3% | 106,123 | -14.0% | 0.00% | -50.0% |
| Q3 2020 | $1,316,000 | -13.5% | 123,338 | +2.3% | 0.01% | -14.3% |
| Q2 2020 | $1,521,000 | +91.1% | 120,555 | +38.6% | 0.01% | +40.0% |
| Q1 2020 | $796,000 | +15.4% | 86,957 | +75.8% | 0.01% | +66.7% |
| Q4 2019 | $690,000 | +216.5% | 49,460 | +289.8% | 0.00% | +200.0% |
| Q3 2019 | $218,000 | -36.8% | 12,690 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $345,000 | – | 12,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |